Skip to content
★ Sign in to follow
셀바

셀바스헬스케어 Stock: price and insider trades · South Korea

KR·Mcap ₩55.3BHealth Care

No insider purchase over the last 90 days. The latest, by 한국증권금융, was filed 09 Apr 2026.

셀바스헬스케어: what insiders have been doing

This page follows insider dealings at 셀바스헬스케어 as filed with DART (FSS), a company from the Health Care sector. The last twelve months, up to 2 November 2026, brought 4 filings signed by 3 insiders.

Open-market activity splits into 2 purchases and 2 sales; 2 insiders sit on the buying side and 2 insiders on the selling side. No amount is published for 4 filings, which the totals therefore leave out. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

The clock since the last published purchase (9 April 2026) now reads 215 days. Between a trade and the moment it shows up on DART (FSS), the median delay is 24 days. That lag is the time during which only the insider knows about the trade.

Compared with its exchange (2,655 companies, median 7 filings), a count of 4 filings is below the norm. Our records for 셀바스헬스케어 go back to 2021, with 4 purchases and 10 sales on the open market in total.

Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.

Insider Decl.
20
Thresholds
n/a
Buy Volume
€3M
4 ops. · all time
Sell Volume
€2M
10 ops. · all time

Who traded when

BuySale
한국증권금융2 buys1 sale
셀바스ai1 sale

Since the insiders bought

  • Filed 09 Apr 2026 · 215 days ago · €274k
    -50.9%
    Entry ₩4,295 · Close 30 Oct 2026 ₩2,110

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Fundamental score
Ranked 7,009 of 26,911 companies
63.6
score / 100
Value
52
Quality
76
FCF yld-1.3%
Earn yld6.3%
EV/EBITDA10.7x
ROE12%
Gross mgn49%
Net mgn13%
Debt/EBITDA0.3x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩2,150
Analyst consensus
·
Income statement
Revenue₩30.8B
Gross profit₩15B49% margin
EBITDA₩5.9B19% margin
Net income₩3.9B27.4% margin
Valuation
Beta-0.76
Balance sheet & cash
Market cap₩55.3B
Total debt₩1.7B
Free Cash Flow-₩796.9M
Debt / Equity3%
Profitability & ownership
ROE12.5%
ROA1.2%
% insiders39.7%
% institutions0.0%
Last declaration on 9 July 2026
Declarations20 total
  • ▼
    Related company / holdingExecutives(filed)
    €391kest.0DART
    261,382 sharesKRXDART:20260709000427
  • ▲
    Related company / holdingExecutives
    €274kest.0DART
    109,889 sharesKRXDART:20260409002757
    Canonical exit: 2 Apr 2026 (T+90)
  • ▲
    Related company / holdingExecutives
    €1.0Mest.0DART
    290,031 sharesKRXDART:20260108000169
    Canonical exit: 15 Mar 2026 (T+90)
  • ▼
    Executives
    €733kest.0DART
    260,801 sharesKRXDART:20251218000349
  • ●
    Executives
    Executives
    0DART
  • ▼
    Related company / holdingExecutives
    €989kest.0DART
    288,842 sharesKRXDART:20240409002061
  • ▲
    Related company / holdingExecutives
    €792kest.0DART
    161,879 sharesKRXDART:20240110000255
    Canonical exit: 21 Feb 2024 (T+90)
  • ▼
    -Executives
    0DART
    ShareKRXDART:20231114000650
  • ●
    Executives
    0DART
    0KRXDART:20231114000666
  • ▼
    -Executives
    0DART
    ShareKRXDART:20230814000831
  • ▼
    -Executives
    0DART
    ShareKRXDART:20230705000265
  • ▼
    -Executives
    0DART
    ShareKRXDART:20230705000262
  • ●
    Executives
    0DART
    0KRXDART:20230705000279
  • ▼
    -Executives(filed)
    0DART
    ShareKRXDART:20230411002828
  • ●
    Executives(filed)
    0DART
    0KRXDART:20230411002825
  • ▼
    -Executives(filed)
    0DART
    ShareKRXDART:20230309000534
  • ▼
    -Executives(filed)
    0DART
    ShareKRXDART:20230309000528
  • ▲
    Executives(filed)
    €570kest.0DART
    250,000 sharesKRXDART:20220406002858
    Canonical exit: 5 Jul 2022 (T+90)
  • ●
    Executives(filed)
    0DART
    0KRXDART:20211001000224
  • ●
    Executives(filed)
    0DART
    0KRXDART:20210406002120

20 of 20 declarations

About 셀바스헬스케어

Selvas Healthcare is a company specializing in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative health solutions and medical technologies.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations